Ticker Symbol: CYTK
Cytokinetics Inc
$39.24 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001061983
Company Profile
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 280 E Grand Ave
Website: www.cytokinetics.com
CEO: Robert Blum
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $26.88
Change:
-$1.00
(
-3.59%)
Days Range: $26.57 - $28.17
Beta: -
52wk. High: $47.64
52wk. Low: $25.98
Ytd. Change -42.74%
50 Day Moving Average: $32.59
200 Day Moving Average: $34.77
Shares Outstanding: 95997998
Valuation
Market Cap: 258.0B
PE Ratio: -4.72
EPS (TTM): -5.69
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A